E16.1

Applicable To

• Functional hyperinsulinism

• Functional nonhyperinsulinemic hypoglycemia

• Hyperinsulinism NOS

• Hyperplasia of pancreatic islet beta cells NOS

Approximate Synonyms

• Hyperinsulinism

• Hyperinsulinism, iatrogenic

• Hyperplasia of pancreatic islet beta cell

• Hypoglycemia low blood sugar), reactive

• Iatrogenic hyperinsulinism

• Reactive hypoglycemia

Clinical Information

• A syndrome with excessively high insulin levels in the blood. It may cause hypoglycemia. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor insulinoma); autoantibodies against insulin insulin antibodies); defective insulin receptor insulin resistance); or overuse of exogenous insulin or hypoglycemic agents.

• Syndrome with excessively high insulin levels in the blood; it may cause hypoglycemia; etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor, autoantibodies against insulin, defective insulin receptor, or overuse of exogeneous insulin or hypoglycemic agents.

Details

• E16.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM E16.1 became effective on October 1, 2022.

• This is the American ICD-10-CM version of E16.1 – other international versions of ICD-10 E16.1 may differ.